Milind Deshpande

Insider Reports History

Location
Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Signature
/s/ Maegan Deare, Attorney-in-Fact for Milind Deshpande
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Milind Deshpande:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 91.5K $66.8K $0.73 Jun 12, 2025 Direct

Insider Reports Filed by Milind Deshpande

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
SPRO Spero Therapeutics, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
SPRO Spero Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 18, 2021 Director